Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY

Journal of Cardiovascular Medicine

Volumn 16, Issue 5, 2015, Pages 341-346

  Kadoglou, Nikolaos P E ^a,b   Tahmatzidis, Dimitrios K ^b   Giannakoulas, Christos ^b   Kapelouzou, Alkistis ^c   Gkontopoulos, Argirios ^b   Parissis, John ^a   Lampropoulos, Stylianos ^b   Kottas, George ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Mamatsio General Hospital   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

adipokines; chemerin; coronary artery disease; myocardial infarction; omentin 1

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHEMERIN; CLOPIDOGREL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; LOW MOLECULAR WEIGHT HEPARIN; OMENTIN 1; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; LIPID; SIGNAL PEPTIDE;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEART EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; CASE CONTROL STUDY; FOLLOW UP; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GPI-LINKED PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; LECTINS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 84926407982     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000053     Document Type: Article

References (23)

1. Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30:1282-1292
2. Kadoglou NP, Avgerinos ED, Liapis CD. An update on markers of carotid atherosclerosis in patients with type 2 diabetes. Biomark Med 2010; 4:601-609
3. Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depotspecific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290:E1253-E1261
4. Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 2010; 20:143-148
5. Yoo HJ, Hwang SY, Hong HC, et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011; 10:103
6. Shang FJ, Wang JP, Liu XT, et al. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011; 16:657-662
7. Roh SG, Song SH, Choi KC, et al. Chemerin: a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007; 362:1013-1018
8. Landgraf K, Friebe D, Ullrich T, et al. Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 2012; 97:E556-E564
9. Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007; 148:4687-4694
10. Lehrke M, Becker A, Greif M, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009; 161:339-344
11. Yan Q, Zhang Y, Hong J, et al. The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 2012; 41:281-288
12. Resnick HE, Harris MI, Brock DB, Harris TB. American Diabetes Association diabetes diagnostic criteria, adVancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23:176-180
13. Shibata R, Ouchi N, Kikuchi R, et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011; 219:811-814
14. Zhong X, Zhang HY, Tan H, et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011; 32:873-878
15. Yan P, Liu D, Long M, et al. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2011; 119:257-263
16. El-Mesallamy HO, El-Derany MO, Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 2011; 28:1194-1200
17. Shibata R, Takahashi R, Kataoka Y, et al. Association of a fat-Derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens Res 2011; 34:1309-1312
18. Dong B, Ji W, Zhang Y. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 2011; 50:1093-1097
19. Becker M, Rabe K, Lebherz C, et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 2010; 59:2898-2903
20. Wittamer V, Bondue B, Guillabert A, et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 2005; 175:487-493
21. Koole D, Heyligers J, Moll FL, Pasterkamp G. Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring. J Cardiovasc Med (Hagerstown) 2012; 13:635-639
22. Gao X, Mi S, Zhang F, et al. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol 2011; 10:87
23. Baldasseroni S, Mannucci E, Di Serio C, et al. Resistin level in coronary artery disease and heart failure: the central role of kidney function. J Cardiovasc Med (Hagerstown) 2013; 14:150-157